Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
Aluminium chloride hexahydrate
Dermal Laboratories Ltd
D11AA
Aluminium chloride hexahydrate
20 percent weight/volume
Cutaneous solution
Product not subject to medical prescription
Antihidrotics
Marketed
1982-03-15
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Anhydrol Forte 20% w/v Cutaneous Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Aluminium Chloride Hexahydrate 20.0 % w/v. For full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Cutaneous solution Clear, colourless, evaporative solution. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the topical treatment of hyperhidrosis specifically involving axillae, hands or feet. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION For adults, children and the elderly. Apply to the affected sites at night, as required, and allow to dry. Wash off in the morning. 4.3 CONTRAINDICATIONS Not to be used in cases of sensitivity to any of the ingredients. Not to be used in axillae within 12 hours of using depilatories or shaving. Not to be used immediately after bathing. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Care should be taken to restrict the application to the affected sites only. Keep away from the eyes and mucous membranes. Care should be taken to avoid Anhydrol Forte coming into direct contact with clothing, polished surfaces, jewellery or metal. Replace cap tightly after use. For external use only. 4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION Do not bathe immediately before use and, if the axillae are treated, do not shave or use depilatories on this area within 12 hours before or after use. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _0_ _7_ _/_ _0_ _9_ _/_ _2_ _0_ _1_ _ Belgenin tamamını okuyun